{
  "pmcid": "9857635",
  "sha256": "bc0f2550c99a1cf5b35a18baa8de66d6d2c244fb3494391365abbf89b26c63c0",
  "timestamp_utc": "2025-11-10T00:13:39.608415+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 12.172312500000004,
    "reading_ease": 30.59143750000004,
    "word_count": 256
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "High-Dose Selenium in Cardiac Surgery: A Randomised Controlled Trial"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "This international, multicenter, double-blind, placebo-controlled trial"
      },
      "Participants": {
        "score": 2,
        "evidence": "Adult cardiac surgery patients with a EuroSCORE II predicted mortality of 5% or more"
      },
      "Intervention": {
        "score": 2,
        "evidence": "high-dose intravenous selenium (2000 Î¼g/L sodium selenite) or placebo"
      },
      "Objective": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the number of days alive and free from organ dysfunction within 30 days post-surgery"
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomization was web-based, stratified by site, and allocation was concealed"
      },
      "Blinding": {
        "score": 3,
        "evidence": "Patients, clinicians, and outcome assessors were blinded"
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "A total of 1416 patients were randomized, with 697 in each group"
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "1394 were analyzed using an intention-to-treat approach"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "odds ratio, 0.82; 95% CI, 0.50-1.36; P = 0.44"
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events were similar between groups, with 8.2% in the selenium group and 8.6% in the placebo group experiencing at least one serious adverse event"
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "ClinicalTrials.gov Identifier: NCT02002247"
      },
      "Funding": {
        "score": 0,
        "evidence": "The trial was funded by [source not specified in the manuscript]"
      }
    },
    "total_score": 23,
    "max_score": 25
  }
}